Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2).

Citation

• Temel, J. S., Currow, D. C., Fearon, K., Yan, Y., Friend, J., & Abernethy, A. P. (2015). Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2).. Journal of Clinical Oncology, 33(15_suppl), 9500. doi:10.1200/jco.2015.33.15_suppl.9500

Digital Object Identifier (doi)

• 10.1200/jco.2015.33.15_suppl.9500

Web Of Science Accession Number

Start Page

• 9500

End Page

• 9500

Volume

• 33

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   Currow, David

Publication Date

• 2015

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Temel, J. S., Currow, D. C., Fearon, K., Yan, Y., Friend, J., & Abernethy, A. P. (2015). Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2).. Journal of Clinical Oncology, 33(15_suppl), 9500. doi:10.1200/jco.2015.33.15_suppl.9500

Digital Object Identifier (doi)

• 10.1200/jco.2015.33.15_suppl.9500

Web Of Science Accession Number

Start Page

• 9500

End Page

• 9500

Volume

• 33

Issue

• 15_suppl

Place Of Publication